tiprankstipranks

Kim Dong Insider Profile

4 Followers
Kim Dong, CFO at Urogen Pharma, holds 26.59K shares in Urogen Pharma (Ticker: URGN).
tipranks
Kim Dong

Kim Dong
Urogen Pharma (URGN)
CFO

Not Ranked
Kim Dong has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$376K
100.00%
A breakdown of Kim Dong's holdings

Insider Roles

Urogen Pharma
(URGN)
CFO
Roles that Kim Dong holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kim Dong

Kim Dong's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Urogen Pharma
Feb 02, 2024
CFO
Uninformative Buy
$376.18K
Kim Dong has not reported any informative transactions for URGN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 02, 2024
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Kim Dong's performance on stock

Kim Dong insider profile FAQ

What is the percentage of profitable transactions made by Kim Dong?
The percentage of profitable transactions made by Kim Dong is ―.
    What is the average return per transaction made by Kim Dong?
    The average return per transaction made by Kim Dong is ―.
      What stocks does Kim Dong hold?
      Kim Dong holds: URGN stocks.
        What was Kim Dong’s latest transaction?
        Kim Dong latest transaction was an Uninformative Buy of ―.
          What was Kim Dong's most profitable transaction?
          Kim Dong’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kim Dong's role in Urogen Pharma?
            Kim Dong's role in Urogen Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.